AlphAIalphai — Financial news for AI agents
yahoo.comAUG 33 min read$USNA

Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow

USANA Health Sciences (NYSE:USNA) is set to report Q2 earnings Tuesday after the bell. Last quarter, it reported $250.2M revenue, flat YoY, and beat analysts on EBITDA and EPS. For Q2, analysts expect flat YoY revenue, after a 10.8% rise last year. The article cites an average analyst price target of $39 versus $22.11.

Original reporting
yahoo.com
Published Aug 3, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 6:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow — source image
Source · yahoo.com
Decision brief

The 30-second read

$USNANeutralMed
01

Why it matters

Traders can use the setup to position for earnings volatility, but the text does not disclose any new company-specific datapoint beyond expectations and recent history.

02

Market read

This is a pre-earnings checklist: flat YoY revenue expectations, reconfirmed estimates, and a reminder that USANA has missed revenue estimates multiple times.

03

What to watch

The article does not discuss guidance, margins, or specific drivers for USANA’s quarter, so traders may be underweighting qualitative commentary risk.

Relevance 4/10Novelty 3/10Timing: after the bell Tuesday earnings release

Background

USANA Health Sciences is heading into its Q2 earnings report after the bell Tuesday; the article summarizes prior-quarter beats and current consensus.

Company-level read

Ticker impact

$USNANeutralMedium confidence
Context

USANA is scheduled to report Q2 earnings after the bell, with the article outlining consensus expectations and recent estimate history.

Expected impact

Likely volatility around the after-hours earnings release, with direction dependent on revenue and margin/EPS beats versus expectations.

Evidence & confidence

The article provides consensus framing (flat YoY revenue) and notes USANA has missed revenue estimates multiple times, which increases downside risk if revenue disappoints.

Market effects

Sector

Limited, since it mainly compares consumer-staples peers’ Q2 results without implying a direct read-across mechanism.

Regional

None specified.

Global

None specified.

Counterpoint

What could challenge this read

If peers’ strong top-line prints (Vita Coco, WD-40) signal demand resilience, USANA could surprise on revenue despite its recent misses.

Key entities

  • company
    USANA Health Sciences

    Subject of the earnings preview, expected to report Q2 results after the bell Tuesday.

Read at source← All news

Related articles

AUG 4
$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N

SEC EDGAR 8-K6 min
AUG 9
$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

peakoil.com4 min
AUG 9
$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

yahoo.com6 min
AUG 9
$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

yahoo.com5 min
AUG 9
$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

yahoo.com6 min